New LaunchJun 10, 2026, 09:46 AM
MindWalk Launches ReefIQ for AI Drug Discovery
AI Summary
MindWalk Holdings Corp. announced the launch of ReefIQ™, a new biological context layer designed for AI drug discovery and biologics development. ReefIQ™ leverages MindWalk's proprietary HYFT® technology to transform fragmented biological data into a governed, queryable context for AI reasoning workflows. This new layer aims to preserve valuable insights from all discovery programs, enriching future efforts and integrating with the company's existing LensAI™ platform, which is already in use with life-sciences customers.
Key Highlights
- MindWalk Holdings Corp. launched ReefIQ™, a biological context layer for AI drug discovery.
- ReefIQ™ transforms fragmented biological data into governed, queryable context for AI reasoning workflows.
- The new product is powered by MindWalk's proprietary HYFT® biological pattern technology.
- ReefIQ™ integrates with LensAI™, MindWalk's reasoning and application layer, which has existing customer contracts.
- The underlying HYFT® system features a Knowledge Graph with 660 million biological patterns and 25 billion relationships.
Price Impact
More from HYFT